Zentalis Pharmaceuticals, Inc.
ZNTL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001725160
In the last 90 days, Zentalis Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 114 institutions reported holding it in 13F filings for Q2 2026, worth $228.9M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Zentalis Pharmaceuticals, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 116
- −3 vs. Q2 2021
- Shares held
- 41.3M
- +1.54M (+3.9%) vs. Q2 2021
- Total value
- $2.75B
- +$636.7M (+30.1%) vs. Q2 2021
- New holders
- 15
- 60 more added
- Sold out
- 18
- 28 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ZNTL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 114 | $228.9M |
| Q1 2026 | 102 | $101.7M |
| Q4 2025 | 86 | $54.9M |
| Q3 2025 | 99 | $79.7M |
| Q2 2025 | 117 | $64.5M |
| Q1 2025 | 132 | $92.9M |
| Q4 2024 | 142 | $195.2M |
| Q3 2024 | 136 | $261.2M |
| Q2 2024 | 145 | $314.3M |
| Q1 2024 | 142 | $1.34B |
| Q4 2023 | 120 | $1.23B |
| Q3 2023 | 137 | $1.61B |
| Q2 2023 | 134 | $2.32B |
| Q1 2023 | 110 | $1.15B |
| Q4 2022 | 106 | $1.30B |
| Q3 2022 | 121 | $1.27B |
| Q2 2022 | 122 | $1.64B |
| Q1 2022 | 128 | $2.05B |
| Q4 2021 | 139 | $3.61B |
| Q3 2021 | 116 | $2.75B |
| Q2 2021 | 120 | $2.13B |
| Q1 2021 | 95 | $1.58B |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Zentalis Pharmaceuticals, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Eventide Asset Management, LLC | 529,000 | $35.3M | 0.47% | +108,600+25.8% | Added |
| Geode Capital Management, LLC | 642,654 | $42.8M | 0.01% | +198,889+44.8% | Added |
| Capital World Investors | 683,000 | $45.5M | 0.01% | +13,000+1.9% | Added |
| Alliancebernstein L.P. | 985,953 | $65.7M | 0.03% | +45,125+4.8% | Added |
| Citadel Advisors LLC | 1,102,793 | $73.5M | 0.08% | −130,187−10.6% | Reduced |
| Federated Hermes, Inc. | 1,282,383 | $85.5M | 0.16% | +7,717+0.6% | Added |
| State Street Corp | 1,292,263 | $86.1M | 0.00% | −47,077−3.5% | Reduced |
| Primecap Management Co | 1,335,620 | $89.0M | 0.06% | −12,990−1.0% | Reduced |
| Viking Global Investors LPSuperinvestorViking Global Investors | 2,118,284 | $141.2M | 0.39% | −281,000−11.7% | Reduced |
| Avidity Partners Management LP | 2,493,800 | $166.2M | 4.24% | +333,800+15.5% | Added |
| Tybourne Capital Management (HK) Ltd | 2,664,409 | $177.6M | 4.47% | 00.0% | Unchanged |
| BlackRock Inc. | 2,755,788 | $183.6M | 0.01% | +435,672+18.8% | Added |
| Vanguard Group Inc | 3,131,885 | $208.7M | 0.01% | +297,061+10.5% | Added |
| Price T Rowe Associates Inc | 3,730,425 | $248.6M | 0.02% | +470,857+14.4% | Added |
| Matrix Capital Management Company, LP | 4,349,279 | $289.8M | 3.30% | +248,540+6.1% | Added |
| FMR LLC | 6,757,935 | $450.3M | 0.04% | +95,710+1.4% | Added |
| Redmile Group, LLC | 0 | $0 | 0.00% | −425,480−100.0% | Sold out |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −91,069−100.0% | Sold out |
| Caas Capital Management LP | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −44,905−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −35,903−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −26,368−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −19,577−100.0% | Sold out |
| Alpha Paradigm Partners, LLC | 0 | $0 | 0.00% | −13,523−100.0% | Sold out |
| Copernicus Capital Management, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Quantitative Systematic Strategies LLC | 0 | $0 | 0.00% | −6,930−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −5,969−100.0% | Sold out |
| Paloma Partners Management Co | 0 | $0 | 0.00% | −5,411−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −5,300−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −4,422−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −2,692−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −103−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Mayo Clinic | – | – | – | – | Not filed |